Search

everythinglearnresearchcommunity

for

Search:↓

Long COVID in Japan involves persistent symptoms like fatigue and may be caused by lasting organ damage and prolonged inflammation, with vaccination as a potential treatment.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Testosterone's effects on COVID-19 are unclear and need more research.

A man's hair grew back to almost normal 7 months after COVID-19 without needing treatment.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

About 61% of women who had COVID-19 experienced hair loss afterward.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

AGA might indicate higher risk for severe COVID-19.